Transitional Care for Patients with Inflammatory Bowel Disease: Japanese Experience

Hideki Kumagai1, Yasuo Suzuki2, Toshiaki Shimizu3

  • 1Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan, h-kumagai@jichi.ac.jp.

Digestion
|October 8, 2020
PubMed

Insights

Successful transition from pediatric to adult care for pediatric inflammatory bowel disease (IBD) patients requires a multidisciplinary approach, patient independence, and tailored care plans. Key elements include coordinated clinics and readiness assessments for better outcomes.

Area of Science:

  • Gastroenterology
  • Pediatric Healthcare
  • Transition Medicine

Background:

  • Pediatric inflammatory bowel disease (IBD) incidence is rising globally, necessitating effective lifelong care strategies.
  • Transitioning IBD patients from pediatric to adult healthcare systems presents unique challenges.
  • Recent Japanese guidelines aim to enhance patient autonomy during this critical transition period.

Purpose of the Study:

  • To review current challenges in pediatric to adult IBD patient transition within the Japanese healthcare system.
  • To identify barriers and essential components for successful patient transition.
  • To propose a standardized referral process and highlight key elements for effective transitional care.

Main Methods:

  • Literature review of current issues in IBD transition care.
  • Analysis of the Japanese healthcare context for pediatric to adult transitions.
  • Identification of best practices and essential elements for successful transition.

Main Results:

  • No single optimal transition model exists; however, joint clinics, multidisciplinary teams, and stakeholder coordination are crucial.
  • Patient self-reliance and maturity are key factors, not just chronological age.
  • Transition readiness assessment tools are valuable, and tailored care improves adherence, quality of life, and self-management.

Conclusions:

  • Effective transition programs require a multidisciplinary approach, a dedicated coordinator (e.g., IBD nurse), and strong collaboration.
  • Standardized medical summaries and checklists can facilitate patient referrals.
  • Addressing resource limitations and funding is essential for program success.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
333
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
531
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
326
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
727
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
357
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
315